Related Experiment Video
Updated: Jun 12, 2026
14:55
Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI
Published on: April 18, 2011
Restless legs syndrome: pathophysiology, clinical presentation and management
Claudia Trenkwalder1, Walter Paulus
1Paracelsus-Elena Hospital, Center of Parkinsonism and Movement Disorders, Klinikstrasse 16, 34128 Kassel, Germany. trenkwalder@pk-mx.de
Nature Reviews. Neurology
|June 10, 2010
Summary
Restless legs syndrome (RLS) is a neurological disorder characterized by an urge to move the legs. Treatment involves dopaminergic agents, opioids, anticonvulsants, and iron supplementation, with augmentation being a key challenge.
Area of Science:
- Neurology
- Sleep Medicine
- Genetics
Background:
- Restless Legs Syndrome (RLS) is a somatosensory network disorder.
- Diagnosed by urge to move legs, worsening at rest, relief with activity, and diurnal fluctuations.
- Genetic variants and various lesions (peripheral neuropathy, spinal cord, brain metabolism) are implicated.
Purpose of the Study:
- To review the latest research on the pathophysiology of RLS.
- To summarize the clinical presentation of RLS.
- To discuss current and emerging management strategies for RLS.
Main Methods:
- Literature review of recent studies on RLS.
- Analysis of genetic, neurological, and metabolic factors.
- Evaluation of pharmacological and non-pharmacological treatments.
Main Results:
- RLS involves genetic predispositions and diverse neurological lesions.
- Polysomnography often reveals sleep fragmentation and periodic limb movements.
- Dopaminergic agents are first-line, with opioids and anticonvulsants as alternatives.
- Augmentation is a significant challenge in RLS management.
- Iron deficiency treatment is crucial for symptom improvement and preventing augmentation.
Conclusions:
- Understanding RLS pathophysiology is key to effective management.
- Personalized treatment approaches are necessary, considering genetics and comorbidities.
- Addressing iron deficiency and monitoring for augmentation are critical for long-term RLS care.
Related Concept Videos
01:27Restless Leg Syndrome and Night Terrors
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
01:15REM Sleep Behavior Disorder
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...